Le Lézard
Classified in: Science and technology
Subjects: NEW PRODUCTS/SERVICES, ANALYSTS' COMMENTS, MISCELLANEOUS, MISCELLANEOUS, MISCELLANEOUS

Act-On Software collaborates with Intel to Accelerate AI Audience Insights to Market


PORTLAND, Ore., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Act-On Software, a leading provider of enterprise marketing automation solutions, is collaborating with technology leader Intel to accelerate development of a new AI-based software capability called Act-On AI Audience Insights.

Act-On AI Audience Insights works by analyzing billions of data points to highlight new segments within a customers database, providing information that yields higher outcome marketing opportunities. Using machine learning to analyze customer behavioral data (email opens, content preferences, and engagement metrics), it can identify unique audience segments to power marketing automation. In a traditional world without AI, marketers would have to create audience segmentations based on manual analysis and best guesses. AI Audience Insights helps the user identify audience segments automatically and in a fraction of the time, accelerating a process crucial to the success of digital marketing. 

Act-On worked with Intel and Intel AI & Machine Learning Software Portfolio to both improve model accuracy and accelerate Act-On's time to market. The Act-On and Intel teams used machine learning to ingest and analyze billions of data points of account and behavioral data, expediting the design and implementation of customized segmentation model. This collaboration is part of Intel's efforts to democratize AI and make AI Everywhere a reality, supercharging developer productivity and performance through Intel AI & Machine Learning Software Portfolio.

Intel's easy-to-use, modular AI software helped create these customer segmentation models that are incorporated into Act-On's marketing automation application. This will allow marketers to more easily explore their own datasets.

"We are very excited about the power of AI to drive exponential improvement in efficiency and accuracy in Marketing Automation, and are investing aggressively to build it into the Act-On platform," said Act-On CEO Kate Johnson. "We are thrilled to have Intel as a collaborator in elevating these data insights to empower marketers toward more effective campaigns and stronger ROI."

Act-On and Intel will share more about the collaborative development process and use of AI at the Intel Innovation event series in San Jose on September 19. Sudhir Kulkarni, Intel VP/GM of Data & AI Platforms, and Syed Ahmed, Act-On Software SVP of Engineering & Operations, will both speak at the event.

"AI innovations have proven to make for an exciting and challenging time for companies across all industries and verticals," Mr Kulkarni said. "This latest collaboration between Intel and Act-On shows one of the many real-world applications of how AI and machine learning can free up time for professionals to focus on the bigger picture."

Attachment



These press releases may also interest you

at 04:09
China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...

at 04:05
H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $64 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to acquire CGH Group S.A. ("CGH" or the "Company"), a...

at 03:55
The International Nut and Dried Fruit Council (INC), conducted an extensive study on Latin America's Gen Z dietary...

at 03:44
Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is publishing its interim report for January-June on Friday 19 July 2024 at 07.30 CET.  Alan Mamedi, CEO and Odd Bolin, CFO presents the report and...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:09
China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...



News published on and distributed by: